Coxiella burnetii (Q fever) as a cause of community-acquired pneumonia during the warm season in Germany

Epidemiology and Infection

Volumn 142, Issue 9, 2014, Pages 1905-1910

  Schack, M ^a   Sachse, S ^a   Rodel J ^a   Frangoulidis, D ^b   Pletz, M W ^a,c   Rohde, G U ^c,d   Straube, E ^a   Boden, K ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b BUNDESWEHR INSTITUTE OF MICROBIOLOGY   (Germany)

^c CAPNETZ Study Group   (United States)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Community acquired pneumonia; Coxiella burnetii; endocarditis; pneumonia; Q fever; zoonoses

Indexed keywords

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHLAMYDOPHILA; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COXIELLA BURNETII; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEGIONELLA; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA; POLYMERASE CHAIN REACTION; PREVALENCE; Q FEVER; SUMMER; BLOOD ANALYSIS; DIAGNOSTIC TEST; ELISA KIT; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT EXAMINATION; SPUTUM ANALYSIS; THORAX RADIOGRAPHY;

ADULT; AGED; COMMUNITY-ACQUIRED INFECTIONS; COXIELLA BURNETII; FEMALE; GERMANY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; Q FEVER; SEASONS;

AMINOPENICILLIN; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN; CLARITHROMYCIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KETOLIDE; LEVOFLOXACIN; MOXIFLOXACIN;

EID: 84904744787     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813002914     Document Type: Article

References (17)

1. Anon. Q fever: increased incidence in spring 2008 [in German]. Epidemiologisches Bulletin 2008; 25: 5.
2. SurvStat. (http://www3.rki.de/SurvStat). Accessed 3 July 2013.
3. Fenollar F, et al. Risks factors and prevention of Q fever endocarditis. Clinical Infectious Disease 2001; 33: 312-316.
4. Botelho-Nevers E, et al. Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. European Journal of Clinical Microbiology and Infectious Diseases 2007; 26: 635-640.
5. Maurin M, Raoult D. Q fever. Clinical Microbiology Reviews 1999; 12: 518-553.
6. Peacock MG, et al. Serological evaluation of Q fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis. Infection and Immunity 1983; 41: 1089-1098.
7. Schneeberger PM, et al. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clinical and Vaccine Immunology 2010; 17: 286-290.
8. Welte T, Suttorp N, Marre R. CAPNETZ communityacquired pneumonia competence network. Infection 2004; 32: 234-238.
9. Fenollar F, Fournier PE, Raoult D. Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection. Journal of Clinical Microbiology 2004; 42: 4919-4924.
10. Takahashi H, et al. Prevalence of community-acquired respiratory tract infections associated with Q fever in Japan. Diagnostic Microbiology and Infectious Disease 2004; 48: 247-252.
11. Lieberman D, et al. Q-fever pneumonia in the Negev region of Israel: a review of 20 patients hospitalised over a period of one year. Journal of infection 1995; 30: 135-140.
12. Capelastegui A, et al. Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes. BMC Infectious Diseases 2012; 12: 134.
13. Wellinghausen N, et al. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia. International Journal of Medical Microbiology 2006; 296: 485-491.
14. Anderson A, et al. Diagnosis and management of Q fever - United States, 2013: recommendations from CDC and the Q Fever Working Group. Morbidity and Mortality Weekly Report 2013; 62: 1-30.
15. Hoffken G, et al. Guidelines of the Paul-Ehrlich-Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia. Pneumologie 2010; 64: 149-154.
16. Schnoor M, et al. Approaches to estimate the population-based incidence of community acquired pneumonia. Journal of infection 2007; 55: 233-239.
17. Boden K, et al. Diagnosis of acute Q fever with emphasis on enzyme-linked immunosorbent assay and nested polymerase chain reaction regarding the time of serum collection. Diagnostic Microbiology and Infectious Disease 2010; 68: 110-116.